UK markets open in 27 minutes

NIKKEI 225
40,580.76
+506.07(+1.26%)
HANG SENG
17,942.65
+173.51(+0.98%)
CRUDE OIL
83.14
+0.33(+0.40%)
GOLD FUTURES
2,344.30
+10.90(+0.47%)
DOW
39,331.85
+162.33(+0.41%)
Bitcoin GBP
48,093.45
-1,441.70(-2.91%)

How to make sure you don’t get underpaid when it comes to state pension

Getting less than you were expecting could come as a nasty surprise but there are things you can do about it

NVS Oct 2024 115.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

8.70

0.00

(0.00%)

At close: 09:45AM EDT

Loading interactive chart…

Zacks
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
Investor's Business Daily
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
A Relative Strength Rating upgrade for Novartis ADR shows improving technical performance. Will it continue?
Zacks
Here's Why Novartis (NVS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.